Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
about
Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infectionEvaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines.Toxin synthesis and mucin breakdown are related to swarming phenomenon in Clostridium septicumInterleukin-8 production by human airway epithelial cells in response to Pseudomonas aeruginosa clinical isolates expressing type a or type b flagellins.Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat.Surface characteristics of Pseudomonas aeruginosa grown in a chamber implant model in mice and ratsGeneration and characterization of murine antiflagellum monoclonal antibodies that are protective against lethal challenge with Pseudomonas aeruginosa.Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection.Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.Opsonophagocytosis of Pseudomonas aeruginosa treated with antiflagellar serum.Smooth lipopolysaccharide is the major protective antigen for mice in the surface extract from IATS serotype 6 contributing to the polyvalent Pseudomonas aeruginosa vaccine PEV.Effect of antiflagellar serum in the protection of mice against Clostridium chauvoeiVirulence of different Pseudomonas species in a burned mouse model: tissue colonization by Pseudomonas cepaciaPolysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patientsIsolation and characterization of flagellar preparations from Pseudomonas speciesRecent developments for Pseudomonas vaccines.Effects of a human antiflagellar monoclonal antibody in combination with antibiotics on Pseudomonas aeruginosa infectionCloning and expression of Pseudomonas aeruginosa flagellin in Escherichia coli.A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa.Intact motility as a Salmonella typhi invasion-related factor.Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition.Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEV.Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.Differentiation of the major flagellar antigens of Pseudomonas aeruginosa by the slide coagglutination technique.Phenotypic factors correlated with the absence of virulence among gentamicin-resistant Pseudomonas aeruginosa strains.Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.Sequence polymorphism in the glycosylation island and flagellins of Pseudomonas aeruginosa.A scalable method for biochemical purification of Salmonella flagellin.Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa
P2860
Q28493023-E171E394-705E-43FF-9550-0B5DA0315611Q33613907-64B4F252-3413-4066-AA6E-42B2A0F12172Q34006087-EBB083A0-DE1E-4D34-9CCE-FDF580DA2710Q34044986-7DFA205C-AE10-4400-B435-9C0718495553Q34543905-42EC9C3F-B956-4D73-BDF1-5C676DBE43CDQ35090066-4C186EC6-5896-45B1-83A8-8733FB2C7D09Q35108367-43E07E29-2B4E-41F7-9657-3283AEBCAA87Q35110825-98A7133A-8899-4A4F-964A-42400E838C0EQ36345672-C15945EB-06B3-420C-8497-A2209008D026Q37009930-2BD217BA-870D-4801-86D8-3207FE15E1E7Q37053810-9C58B357-7324-40C1-9E37-F6CF1F66A6ABQ37098992-D057CC68-AD85-4842-93AB-D8437ADBF452Q37105554-E8249ECB-6834-4984-AED6-19CD58D4B0DBQ37208228-72381DBB-7D9B-4979-8E0C-F79297460E75Q37255909-C353ECB0-2895-452A-80B5-D7B2FDC4CB99Q37937369-F09F4825-1EC8-4CD3-9063-27967B592AC6Q39874977-57786FB9-12BE-4534-AA99-75A1E67D693EQ39950980-5AAF8947-6AE5-443C-8E49-67EBA4D5A0B2Q40149450-32F650C4-FB30-4B95-A35B-D9FD7A1F621BQ40149884-EC470D21-8056-4A9C-A0F6-D0F8F480983BQ40158474-B5D34380-F643-4CAC-8285-C927D559470BQ40170508-CB2B3905-8AB7-4765-80A4-DDDFB5A86625Q40172509-827583E4-8164-49A0-921A-23B765645124Q40181441-8D0F904A-C7B8-4A62-B139-19AB2ECF477CQ40218729-E3495D4E-C786-44DB-9F8E-01CE6FCFDA14Q40218938-E06BDE10-F894-4B2D-995D-7FCA16C75A98Q40600347-D776FB97-FBC1-4238-805F-E25FCB188A50Q40700934-372E5364-A090-48DE-93E5-6319E6BD5602Q42915324-484EF1E2-F807-488D-BFAE-15EC72D05037Q58762161-E6A77217-DF8E-4AAC-85A2-8EE383606FB4
P2860
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
@ast
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
@en
type
label
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
@ast
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
@en
prefLabel
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
@ast
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
@en
P2093
P2860
P1476
Flagellar preparations from Pseudomonas aeruginosa: animal protection studies.
@en
P2093
P2860
P304
P407
P577
1982-01-01T00:00:00Z